Balance Sheet ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-21 pm EST			5-day change	1st Jan Change
205.07 ^USD	+3.51%		+2.41%	-2.21%

Jan. 14	ICON Public Limited Company Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 03:45 PM
Jan. 14	ICON Reaffirms 2024 Outlook, Provides 2025 Guidance; Shares Down Pre-Bell	MT

9.AOyhkUP7dV64u7jiwmTXqOY9KGfd1sS2O03Yr8ELCzk.co3RwQqOOXOJ8_aJk0mym6xYGSOYvI3VUSjuzLRGO1NSlvTlNpM8b-v-0w

Published financial data: ICON PUBLIC LIMITED COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.81B	2.8B	5.48B	7.74B	8.12B
Total Revenues	2.81B	2.8B	5.48B	7.74B	8.12B
Cost of Goods Sold, Total	1.97B	1.98B	3.97B	5.52B	5.71B
Gross Profit	834M	820M	1.51B	2.22B	2.41B
Selling General & Admin Expenses, Total	339M	344M	588M	783M	776M
Stock-Based Compensation (IS)	-	-	73.84M	-	-
Depreciation & Amortization - (IS)	61.55M	66.13M	315M	570M	586M
Other Operating Expenses, Total	400M	410M	977M	1.35B	1.36B
Operating Income	434M	410M	534M	866M	1.05B
Interest Expense, Total	-13.28M	-13.02M	-182M	-230M	-337M
Interest And Investment Income	6.86M	2.72M	574K	2.34M	5.01M
Net Interest Expenses	-6.42M	-10.3M	-182M	-227M	-332M
Income (Loss) On Equity Invest.	-	-366K	-2.16M	-3.14M	-383K
EBT, Excl. Unusual Items	427M	399M	350M	636M	714M
Restructuring Charges	-	-18.09M	-31.1M	-31.14M	-45.39M
Merger & Related Restructuring Charges	-300K	-	-124M	-39.7M	-44.18M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	427M	381M	195M	565M	624M
Income Tax Expense	51.13M	47.88M	41.33M	59.41M	11.75M
Earnings From Continuing Operations	376M	333M	153M	505M	612M
Net Income to Company	376M	333M	153M	505M	612M
Minority Interest	-1.87M	-633K	-	-	-
Net Income - (IS)	374M	332M	153M	505M	612M
Preferred Dividend and Other Adjustments	5.05M	4.52M	-	-	-
Net Income to Common Incl Extra Items	369M	328M	153M	505M	612M
Net Income to Common Excl. Extra Items	369M	328M	153M	505M	612M
Per Share Items
Net EPS - Basic	6.85	6.2	2.28	6.2	7.46
Basic EPS - Continuing Operations	6.85	6.2	2.28	6.2	7.46
Basic Weighted Average Shares Outstanding	53.86M	52.86M	67.11M	81.53M	82.1M
Net EPS - Diluted	6.79	6.15	2.25	6.13	7.4
Diluted EPS - Continuing Operations	6.79	6.15	2.25	6.13	7.4
Diluted Weighted Average Shares Outstanding	54.33M	53.28M	68.07M	82.47M	82.72M
Normalized Basic EPS	4.92	4.7	3.26	4.87	5.43
Normalized Diluted EPS	4.88	4.67	3.21	4.82	5.39
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	495M	476M	849M	1.44B	1.63B
EBITA	450M	429M	774M	1.33B	1.51B
EBIT	434M	410M	534M	866M	1.05B
EBITDAR	528M	506M	899M	1.49B	1.68B
Total Revenues (As Reported)	2.81B	-	-	-	-
Effective Tax Rate - (Ratio)	11.98	12.57	21.25	10.52	1.88
Current Domestic Taxes	35.96M	28.96M	18.47M	53.25M	80.43M
Current Foreign Taxes	16.72M	17.98M	83.48M	131M	16.72M
Total Current Taxes	52.67M	46.95M	102M	184M	97.15M
Deferred Domestic Taxes	2.83M	1.65M	553K	-6.17M	45.25M
Deferred Foreign Taxes	-4.37M	-727K	-61.17M	-119M	-131M
Total Deferred Taxes	-1.54M	927K	-60.62M	-125M	-85.4M
Normalized Net Income	265M	249M	219M	397M	446M
Interest on Long-Term Debt	-	-	-	-	337M
Non-Cash Pension Expense	263K	-326K	119K	-358K	-314K
Supplemental Operating Expense Items
Advertising Expense	8.09M	7.02M	-	-	-
Selling and Marketing Expenses	8.09M	7.02M	-	-	-
Net Rental Expense, Total	33M	30.15M	49.9M	52.72M	45.72M
Imputed Operating Lease Interest Expense	8.72M	7.07M	23.96M	18.5M	28.09M
Imputed Operating Lease Depreciation	24.28M	23.08M	25.94M	34.22M	17.63M
Stock-Based Comp., COGS (Total)	14.78M	8.56M	18.55M	22.85M	26.6M
Stock-Based Comp., SG&A Exp. (Total)	12.04M	17.71M	41.46M	47.67M	29.07M
Stock-Based Comp., Other (Total)	-	-	73.84M	-	-
Total Stock-Based Compensation	26.82M	26.27M	134M	70.52M	55.67M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	520M	840M	752M	289M	378M
Short Term Investments	49.63M	1.73M	1.71M	1.71M	1.95M
Total Cash And Short Term Investments	570M	842M	754M	290M	380M
Accounts Receivable, Total	950M	1.14B	1.97B	2.69B	2.74B
Other Receivables	63.05M	63.51M	107M	112M	157M
Total Receivables	1.01B	1.21B	2.07B	2.8B	2.9B
Inventory	3.2M	4.8M	5.8M	-	-
Prepaid Expenses	38.32M	48.68M	109M	137M	132M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	1.62B	2.1B	2.94B	3.23B	3.41B
Gross Property Plant And Equipment	787M	781M	997M	904M	921M
Accumulated Depreciation	-517M	-522M	-463M	-400M	-420M
Net Property Plant And Equipment	270M	259M	535M	504M	502M
Long-term Investments	10.05M	20.3M	24.96M	32.63M	46.8M
Goodwill	883M	936M	9.04B	8.97B	9.02B
Other Intangibles, Total	67.89M	66.46M	4.71B	4.28B	3.86B
Deferred Tax Assets Long-Term	16.68M	12.7M	48.39M	76.93M	73.66M
Other Long-Term Assets, Total	34.67M	38M	89.19M	92.17M	78.47M
Total Assets	2.91B	3.44B	17.39B	17.19B	16.99B
Liabilities
Accounts Payable, Total	55.58M	102M	227M	205M	262M
Accrued Expenses, Total	300M	300M	737M	802M	718M
Short-term Borrowings	350M	-	-	-	-
Current Portion of Long-Term Debt	-	-	55.15M	55.15M	110M
Current Portion of Leases	28.32M	24.33M	49.95M	43.66M	36.41M
Current Income Taxes Payable	12.03M	12.18M	59.43M	41.78M	13.97M
Unearned Revenue Current, Total	367M	661M	1.32B	1.51B	1.65B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	18.9M	25.39M	26.64M	35.26M	29.56M
Total Current Liabilities	1.13B	1.12B	2.48B	2.69B	2.83B
Long-Term Debt	-	348M	5.38B	4.6B	3.67B
Long-Term Leases	76.59M	60.8M	159M	132M	126M
Unearned Revenue Non Current	813K	838K	735K	-	-
Pension & Other Post Retirement Benefits	6.05M	10.4M	16.26M	13.03M	14.74M
Deferred Tax Liability Non Current	9.48M	10.41M	1.09B	989M	899M
Other Non Current Liabilities	25.76M	30.51M	198M	264M	218M
Total Liabilities	1.25B	1.59B	9.32B	8.69B	7.75B
Common Stock, Total	4.64M	4.58M	6.64M	6.65M	6.7M
Additional Paid In Capital	578M	617M	6.73B	6.84B	6.94B
Retained Earnings	1.11B	1.26B	1.42B	1.82B	2.43B
Comprehensive Income and Other	-74.77M	-34.34M	-89.8M	-170M	-142M
Total Common Equity	1.62B	1.85B	8.07B	8.5B	9.24B
Minority Interest	39.51M	-	-	-	-
Total Equity	1.66B	1.85B	8.07B	8.5B	9.24B
Total Liabilities And Equity	2.91B	3.44B	17.39B	17.19B	16.99B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	53.62M	52.79M	81.55M	81.72M	82.5M
ECS Total Common Shares Outstanding	53.62M	52.79M	81.55M	81.72M	82.5M
Book Value / Share	30.18	35.05	98.91	103.98	112.02
Tangible Book Value	667M	848M	-5.68B	-4.75B	-3.64B
Tangible Book Value Per Share	12.44	16.06	-69.67	-58.15	-44.09
Total Debt	455M	434M	5.65B	4.83B	3.94B
Net Debt	-115M	-408M	4.89B	4.54B	3.56B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.05M	10.4M	8.27M	-5.08M	-3.92M
Debt Equivalent Oper. Leases	264M	241M	399M	422M	366M
Minority Interest, Total (Incl. Fin. Div)	39.51M	-	-	-	-
Equity Method Investments, Total	-	4.53M	2.37M	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	3.72M	3.72M	3.72M	3.72M	3.72M
Buildings, Total	84.6M	84.2M	82.02M	70.88M	70.07M
Machinery, Total	563M	573M	643M	611M	652M
Full Time Employees	12.31K	13.21K	38.33K	41.1K	41.1K
Part Time Employees	2.34K	2.52K	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	7.38M	7.15M	7.08M	20.56M	31.53M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	374M	332M	153M	505M	612M
Depreciation & Amortization - CF	75.98M	46.89M	75.48M	106M	126M
Amortization of Goodwill and Intangible Assets - (CF)	15.95M	19.23M	240M	463M	460M
Depreciation & Amortization, Total	91.92M	66.13M	315M	570M	586M
Amortization of Deferred Charges, Total - (CF)	540K	523K	12.89M	17.75M	16.4M
(Gain) Loss From Sale Of Asset	346K	141K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-178K	-3.64M	891K	-	-
Asset Writedown & Restructuring Costs	-	5.41M	20.04M	28.77M	8.69M
(Income) Loss On Equity Investments - (CF)	-	366K	2.16M	3.14M	383K
Stock-Based Compensation (CF)	26.82M	26.27M	134M	70.52M	55.67M
Other Operating Activities, Total	1.85M	31.66M	56.15M	-81.46M	-3.57M
Change In Accounts Receivable	-157M	-181M	95.86M	-753M	-78.58M
Change In Accounts Payable	3.44M	26.49M	-	-	-
Change in Unearned Revenues	86.57M	292M	-69.12M	193M	135M
Change In Income Taxes	734K	-1.76M	-	-	-
Change in Other Net Operating Assets	-16.15M	-26.93M	108M	10.12M	-171M
Cash from Operations	413M	568M	829M	563M	1.16B
Capital Expenditure	-50.64M	-51.06M	-93.75M	-142M	-141M
Cash Acquisitions	-120M	-37.76M	-5.91B	-	-71.77M
Investment in Marketable and Equity Securities, Total	8.19M	42.24M	-6.01M	-3.71M	-14.2M
Other Investing Activities, Total	-	-	-10M	-	-
Cash from Investing	-162M	-46.58M	-6.02B	-146M	-227M
Short Term Debt Issued, Total	-	350M	-	-	-
Long-Term Debt Issued, Total	-	-	5.91B	75M	370M
Total Debt Issued	-	350M	5.91B	75M	370M
Short Term Debt Repaid, Total	-	-350M	-	-	-
Long-Term Debt Repaid, Total	-	-	-878M	-875M	-1.26B
Total Debt Repaid	-	-350M	-878M	-875M	-1.26B
Issuance of Common Stock	21.64M	13.2M	119M	35.84M	50.97M
Repurchase of Common Stock	-147M	-175M	-	-99.98M	-
Other Financing Activities, Total	-120K	-46.54M	-31.18M	-34K	-16K
Cash from Financing	-125M	-208M	5.11B	-864M	-844M
Foreign Exchange Rate Adjustments	-650K	6.87M	-7.73M	-16.72M	-997K
Net Change in Cash	124M	320M	-88.09M	-463M	89.33M
Supplemental Items
Cash Interest Paid	13.06M	13.06M	106M	211M	318M
Cash Income Tax Paid (Refund)	29.84M	27.6M	55.1M	116M	164M
Levered Free Cash Flow	293M	430M	936M	380M	955M
Unlevered Free Cash Flow	301M	438M	1.04B	506M	1.15B
Change In Net Working Capital	37.95M	-140M	-348M	533M	5.58M
Net Debt Issued / Repaid	-	0	5.03B	-800M	-895M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	10.3	8.07	3.21	3.13	3.82
Return on Total Capital	14.21	11.65	4.17	4	4.93
Return On Equity %	24.96	18.98	3.09	6.1	6.9
Return on Common Equity	24.82	18.9	3.09	6.1	6.9
Margin Analysis
Gross Profit Margin %	29.73	29.31	27.56	28.66	29.65
SG&A Margin	12.08	12.3	10.72	10.12	9.56
EBITDA Margin %	17.65	17.01	15.49	18.54	20.09
EBITA Margin %	16.03	15.33	14.11	17.17	18.54
EBIT Margin %	15.46	14.64	9.74	11.19	12.88
Income From Continuing Operations Margin %	13.4	11.9	2.79	6.53	7.54
Net Income Margin %	13.33	11.88	2.79	6.53	7.54
Net Avail. For Common Margin %	13.15	11.72	2.79	6.53	7.54
Normalized Net Income Margin	9.45	8.89	3.99	5.13	5.49
Levered Free Cash Flow Margin	10.46	15.38	17.07	4.91	11.76
Unlevered Free Cash Flow Margin	10.74	15.65	18.92	6.53	14.15
Asset Turnover
Asset Turnover	1.07	0.88	0.53	0.45	0.48
Fixed Assets Turnover	13.09	10.58	13.81	14.91	16.15
Receivables Turnover (Average Receivables)	3.25	2.67	3.52	3.33	2.99
Inventory Turnover (Average Inventory)	716.96	494.35	749.1	-	-
Short Term Liquidity
Current Ratio	1.44	1.87	1.19	1.2	1.21
Quick Ratio	1.4	1.82	1.14	1.15	1.16
Operating Cash Flow to Current Liabilities	0.36	0.51	0.33	0.21	0.41
Days Sales Outstanding (Average Receivables)	112.41	137.02	103.55	109.74	122.07
Days Outstanding Inventory (Average Inventory)	0.51	0.74	0.49	-	-
Average Days Payable Outstanding	9.45	14.53	15.1	14.28	14.94
Cash Conversion Cycle (Average Days)	103.47	123.23	88.94	-	-
Long Term Solvency
Total Debt/Equity	27.42	23.44	69.99	56.83	42.62
Total Debt / Total Capital	21.52	18.99	41.17	36.24	29.88
LT Debt/Equity	4.62	22.12	68.68	55.67	41.03
Long-Term Debt / Total Capital	3.63	17.92	40.41	35.5	28.77
Total Liabilities / Total Assets	42.99	46.15	53.6	50.55	45.61
EBIT / Interest Expense	32.67	31.46	2.93	3.77	3.11
EBITDA / Interest Expense	39.79	38.86	4.93	6.48	4.98
(EBITDA - Capex) / Interest Expense	35.98	34.93	4.41	5.86